表紙
市場調查報告書

全球人工授精市場分析與預測:各類型(子宮腔內人工授精、子宮頸内人工授精、陰道內人工授精、輸卵管內移植)、終端用戶、提供者、地區 2018年∼2025年

Artificial Insemination Market Size, Share & Trends Analysis Report By End Use (Home, Fertility Clinics & Other Facilities), By Type (Intrauterine, Intravaginal), By Source Type (AIH, AID), And Segment Forecasts, 2019 - 2026

出版商 Grand View Research, Inc. 商品編碼 656111
出版日期 內容資訊 英文 100 Pages
商品交期: 2-3個工作天內
價格
Back to Top
全球人工授精市場分析與預測:各類型(子宮腔內人工授精、子宮頸内人工授精、陰道內人工授精、輸卵管內移植)、終端用戶、提供者、地區 2018年∼2025年 Artificial Insemination Market Size, Share & Trends Analysis Report By End Use (Home, Fertility Clinics & Other Facilities), By Type (Intrauterine, Intravaginal), By Source Type (AIH, AID), And Segment Forecasts, 2019 - 2026
出版日期: 2019年06月24日內容資訊: 英文 100 Pages
簡介

全球人工授精市場,預計至2025年成長到26億3,000萬美元規模的市場。不孕症是全球性的問題,人工授精作為不孕症的一線治療。生活習慣的變化,生產年齡的上升,荷爾蒙相關問題等,促使不孕症增加。

本報告提供全球人工受精市場調查,市場概要,各類型、終端用戶、提供者、地區的市場規模的變化與預測,市場趨勢,市場佔有率,市場成長要素及阻礙因素分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 摘要整理

  • 市場概述

第2章 調查方法

  • 資訊採購
  • 資料分析

第3章 市場變數、趨勢、範圍

  • 市場區隔和範圍
  • 成長預測製圖
  • SWOT分析(政治,法律,經濟,技術)
  • 波特的五力分析

第4章 人工授精市場分析與預測:各類型

  • 市場趨勢分析:各類型
  • 子宮腔內人工授精(IUI)
  • 子宮頸内人工授精(ICI)
  • 陰道內人工授精
  • 輸卵管內移植

第5章 人工授精市場分析與預測:各終端用戶

  • 市場趨勢分析:各終端用戶
  • 不孕治療診所、其他
  • 家庭治療

第6章 人工授精市場分析與預測:各提供者

  • 市場趨勢分析:各提供者
  • 配偶間人工授精(AIH)
  • 非配偶間人工授精(AID)

第7章 人工授精市場分析與預測:各地區

  • 市場趨勢分析:各地區
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
  • 亞太地區
    • 日本
    • 中國
    • 印度
  • 南美
    • 巴西
    • 墨西哥
  • 中東、非洲
    • 南非

第8章 競爭情形

  • 策略架構
  • 企業簡介
    • Vitrolife AB
    • Genea Limited
    • Rinovum Women's Health LLC
    • Pride Angel
    • Hi-Tech Solutions
    • Irvine Scientific
    • Kitazato
    • Rocket Medical PLC

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GVR-2-68038-176-4

The global artificial insemination market size is expected to reach USD 2.9 billion by 2026 registering a CAGR of 8.4%, according to a new report by Grand View Research, Inc. Over the past few years, infertility has become a major public health concern across the globe. Artificial insemination is usually the preferred first-line treatment to tackle infertility. Lifestyle changes, delay in pregnancy, and hormonal issues are some of the reasons contributing to the rise in fertility-related problems. According to the United Nations, the global fertility rate is expected to decline to 2.2% by 2050. In developing or underdeveloped nations, medical consultation regarding infertility was not easily accessible.

Hence, there was a lack of awareness about available assisted reproductive techniques including artificial or donor insemination and IVF. The average cost of performing an IUI is around USD 865. The success rate for each cycle is around 4 to 5%, which can be increased to about 7 to 16% by consuming fertility drugs. However, older women are not encouraged to go through IUI due to slim chances of success and further complications. Several fertility problems can be addressed through IUI, such as semen allergy, unexplained infertility, and Sexually Transmitted Diseases (STDs).

Further key findings from the study suggest:

  • Artificial insemination is a first-line of infertility treatment, as it is minimally invasive and less expensive as compared to IVF
  • In some countries, such as U.S. and U.K., same-sex couples are provided insurance coverage for artificial insemination procedures
  • Intrauterine insemination held majority of the market share in 2018 and is likely to be the fastest-growing segment over the forecast period as it is the most common and non-invasive procedure
  • Fertility clinics held a majority of the market share in the year 2018 due to higher number of medical facilities offering infertility treatments
  • Europe held a majority of the market share in the year 2018. North America was the second-largest market in 2018

Some of the key companies in the global artificial insemination market include: Vitrolife; Genea Ltd.; Rinovum Women's Health, LLC; Pride Angel; Hi-Tech Solutions; FUJIFILM Irvine Scientific; Kitazato Corp.; and Rocket Medical plc.

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Type
    • 1.1.2 End Use
    • 1.1.3 Source Type
    • 1.1.4 Regional Scope
    • 1.1.5 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR'S Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
    • 1.6.2 Volume Price Analysis (Model 2)
  • 1.7 List of Secondary Sources
  • 1.8 Objectives
    • 1.8.1 Objective - 1
    • 1.8.2 Objective - 2

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
    • 2.2.1 Type
    • 2.2.2 End Use
    • 2.2.3 Source Type
    • 2.2.4 Region
  • 2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Segmentation
  • 3.2 Penetration & Growth Prospect Mapping
    • 3.2.1 Penetration Analysis
    • 3.2.2 Market Driver Analysis
      • 3.2.2.1 Constant rise in infertility rate
      • 3.2.2.2 Growing awareness and social acceptance of assisted reproductive technologies
      • 3.2.2.3 Single women and same-sex couples prefer artificial insemination
    • 3.2.3 Market Restraint Analysis
      • 3.2.3.1 Unsupportive government regulations in certain areas
  • 3.3 Artificial insemination Market: Business Environment Analysis Tools

Chapter 4 Artificial Insemination Market: Type Analysis

  • 4.1 Artificial Insemination Type Market Share Analysis, 2018 & 2026
  • 4.2 Artificial insemination Type Market: Segment Dashboard:
  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Type Segment
    • 4.3.1 Intrauterine Insemination
      • 4.3.1.1 Intrauterine insemination market, 2015 - 2026 (USD Million)
    • 4.3.2 Intracervical Insemination
      • 4.3.2.1 Intracervical insemination market, 2015 - 2026 (USD Million)
    • 4.3.3 Intravaginal Insemination
      • 4.3.3.1 Intravaginal insemination market, 2015 - 2026 (USD Million)
    • 4.3.4 Intratubal Insemination
      • 4.3.4.1 Intratubal insemination market, 2015 - 2026 (USD Million)

Chapter 5 Artificial Insemination Market: End Use Analysis

  • 5.1 Artificial Insemination End Use Market Share Analysis, 2018 & 2026
  • 5.2 Artificial insemination End Use Market: Segment Dashboard:
  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the End Use Segment
    • 5.3.1 Fertility Clinics & Other Facilities
      • 5.3.1.1 Fertility clinics & other facilities Facilities market, 2015 - 2026 (USD Million)
    • 5.3.2 HOME
      • 5.3.2.1 home market, 2015 - 2026 (USD Million)

Chapter 6 Artificial Insemination Market: Source Type Analysis

  • 6.1 Artificial Insemination Source Type Market Share Analysis, 2018 & 2026
  • 6.2 Artificial insemination Source Type Market: Segment Dashboard:
  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Source Type Segment
    • 6.3.1 AIH-HUSBAND
      • 6.3.1.1 AIH-Husband market, 2015 - 2026 (USD Million)
    • 6.3.2 AID-DONOR
      • 6.3.2.1 AID-Donor market, 2015 - 2026 (USD Million)

Chapter 7 Artificial Insemination Market: Regional Analysis

  • 7.1 Artificial Insemination Regional Market Share Analysis, 2018 & 2026
  • 7.2 Artificial Insemination Regional Market: Segment Dashboard
  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
  • 7.4 Market Size, & Forecasts, and Trend Analysis, 2015 to 2026
    • 7.4.1 North America
      • 7.4.1.1 North America Artificial insemination market, 2015 - 2026 (USD Million)
      • 7.4.1.1.1 U.S.
      • 7.4.1.1.1.1 U.S. Artificial insemination market, 2015 - 2026 (USD Million)
      • 7.4.1.1.2 Canada
      • 7.4.1.1.2.1 Canada Artificial insemination market, 2015 - 2026 (USD Million)
    • 7.4.2 Europe
      • 7.4.2.1 Europe Artificial insemination market, 2015 - 2026 (USD Million)
      • 7.4.2.1.1 U.K.
      • 7.4.2.1.1.1 U.K. Artificial insemination market, 2015 - 2026 (USD Million)
      • 7.4.2.1.2 Germany
      • 7.4.2.1.2.1 Germany Artificial insemination market, 2015 - 2026 (USD Million)
    • 7.4.3 Asia Pacific
      • 7.4.3.1 Asia Pacific Artificial insemination market, 2015 - 2026 (USD Million)
      • 7.4.3.1.1 Japan
      • 7.4.3.1.1.1 Japan Artificial insemination market, 2015 - 2026 (USD Million)
      • 7.4.3.1.2 China
      • 7.4.3.1.2.1 China Artificial insemination market, 2015 - 2026 (USD Million)
      • 7.4.3.1.3 India
      • 7.4.3.1.3.1 India Artificial insemination market, 2015 - 2026 (USD Million)
    • 7.4.4 Latin America
      • 7.4.4.1 Latin America Artificial insemination market, 2015 - 2026 (USD Million)
      • 7.4.4.1.1 Brazil
      • 7.4.4.1.1.1 Brazil Artificial insemination market, 2015 - 2026 (USD Million)
      • 7.4.4.1.2 Mexico
      • 7.4.4.1.2.1 Mexico Artificial insemination market, 2015 - 2026 (USD Million)
    • 7.4.5 Middle East And Africa (MEA)
      • 7.4.5.1 MEA Artificial insemination market, 2015 - 2026 (USD Million)
      • 7.4.5.1.1 South Africa
      • 7.4.5.1.1.1 South Africa Artificial insemination market, 2015 - 2026 (USD Million)

Chapter 8 Competitive Analysis

  • 8.1 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
  • 8.2 Company Profiles
    • 8.2.1 VITROLIFE
      • 8.2.1.1 Company overview
      • 8.2.1.2 Financial performance
      • 8.2.1.3 Product benchmarking
      • 8.2.1.4 Strategic initiatives
    • 8.2.2 GENEA LIMITED
      • 8.2.2.1 Company overview
      • 8.2.2.2 Product benchmarking
      • 8.2.2.3 Strategic initiatives
    • 8.2.3 RINOVUM WOMEN'S HEALTH, LLC
      • 8.2.3.1 Company Overview
      • 8.2.3.2 Product benchmarking
      • 8.2.3.3 STRATEGIC INITIATIVES
    • 8.2.4 PRIDE ANGEL
      • 8.2.4.1 Company overview
      • 8.2.4.2 Product benchmarking
    • 8.2.5 HI-TECH SOLUTIONS
      • 8.2.5.1 Company overview
      • 8.2.5.2 Product benchmarking
    • 8.2.6 FUJIFILM IRVINE SCIENTIFIC
      • 8.2.6.1 Company overview
      • 8.2.6.2 Product benchmarking
      • 8.2.6.3 Strategic initiatives
    • 8.2.7 KITAZATO CORPORATION
      • 8.2.7.1 Company overview
      • 8.2.7.2 Product benchmarking
      • 8.2.7.3 Strategic initiatives
    • 8.2.8 ROCKET MEDICAL PLC
      • 8.2.8.1 Company overview
      • 8.2.8.2 Product benchmarking

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 Occurrence of infertility among couples
  • TABLE 3 Factors affecting fertility
  • TABLE 4 Fertility rate, by region
  • TABLE 5 North America artificial insemination market, by country, 2015 - 2026 (USD Million)
  • TABLE 6 North America artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 7 North America artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 8 North America artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 9 U.S. artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 10 U.S. artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 11 U.S. artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 12 Canada artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 13 Canada artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 14 Canada artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 15 Europe artificial insemination market, by country, 2015 - 2026 (USD Million)
  • TABLE 16 Europe artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 17 Europe artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 18 Europe artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 19 U.K. artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 20 U.K. artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 21 U.K. artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 22 Germany artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 23 Germany artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 24 Germany artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 25 Asia Pacific artificial insemination market, by country, 2015 - 2026 (USD Million)
  • TABLE 26 Asia Pacific artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 27 Asia Pacific artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 28 Asia Pacific artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 29 Japan artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 30 Japan artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 31 Japan artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 32 China artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 33 China artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 34 China artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 35 India artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 36 India artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 37 India artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 38 Latin America artificial insemination market, by country, 2015 - 2026 (USD Million)
  • TABLE 39 Latin America artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 40 Latin America artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 41 Latin America artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 42 Brazil artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 43 Brazil artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 44 Brazil artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 45 Mexico artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 46 Mexico artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 47 Mexico artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 48 MEA artificial insemination market, by country, 2015 - 2026 (USD Million)
  • TABLE 49 MEA artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 50 MEA artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 51 MEA artificial insemination market, by source type, 2015 - 2026 (USD Million)
  • TABLE 52 South Africa artificial insemination market, by type, 2015 - 2026 (USD Million)
  • TABLE 53 South Africa artificial insemination market, by end use, 2015 - 2026 (USD Million)
  • TABLE 54 South Africa artificial insemination market, by source type, 2015 - 2026 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Artificial insemination market outlook, 2018
  • Fig. 9 Artificial insemination market segmentation
  • Fig. 10 Penetration & growth prospect mapping
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Artificial insemination market - PESTLE analysis
  • Fig. 14 Artificial insemination type market: Porter's five forces model
  • Fig. 15 Artificial insemination type market share analysis, 2018 & 2026
  • Fig. 16 Artificial insemination type market: Segment dashboard
  • Fig. 17 Intrauterine insemination market, 2015 - 2026 (USD Million)
  • Fig. 18 Intracervical insemination market, 2015 - 2026 (USD Million)
  • Fig. 19 Intravaginal insemination market, 2015 - 2026 (USD Million)
  • Fig. 20 Intratubal insemination market, 2015 - 2026 (USD Million)
  • Fig. 21 Artificial insemination end use market share analysis, 2018 & 2026
  • Fig. 22 Artificial insemination end use market: Segment dashboard
  • Fig. 23 Fertility clinics & other facilitiess market, 2015 - 2026 (USD Million)
  • Fig. 24 Home market, 2015 - 2026 (USD Million)
  • Fig. 25 Artificial insemination source type market share analysis, 2018 & 2026
  • Fig. 26 Artificial insemination source type market: Segment dashboard
  • Fig. 27 AIH-husband market, 2015 - 2026 (USD Million)
  • Fig. 28 AID-donor market, 2015 - 2026 (USD Million)
  • Fig. 29 Artificial insemination regional market share analysis, 2018 & 2026
  • Fig. 30 Artificial insemination regional market: Segment dashboard
  • Fig. 31 Regional market place: Key takeaways
  • Fig. 32 North America artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 33 U.S. artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 34 Canada artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 35 Europe artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 36 U.K. artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 37 Germany artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 38 Asia Pacific artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 39 Japan artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 40 China artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 41 India artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 42 Latin America artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 43 Brazil artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 44 Mexico artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 45 MEA artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 46 South Africa artificial insemination market, 2015 - 2026 (USD Million)
  • Fig. 47 Strategy framework
Back to Top